Surgical valvotomy versus balloon dilatation for children with severe aortic valve stenosis: a systematic review

Huzeifa Elhedai1, Salma Saeed S Mohamed2, Hamid Idriss3

  • 1Department of Cardiology, Birmingham Women's & Children's NHS Foundation Trust, Birmingham, UK.

Future Cardiology
|September 5, 2022
PubMed

Insights

Surgical aortic valvotomy (SAV) and balloon aortic dilatation (BAD) show similar survival rates for severe aortic stenosis. SAV offers better gradient reduction and lower aortic regurgitation post-procedure.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Severe aortic stenosis (AS) necessitates intervention to improve patient outcomes.
  • Surgical aortic valvotomy (SAV) and balloon aortic dilatation (BAD) are primary treatment options.
  • Comparative effectiveness of SAV versus BAD for severe AS requires detailed evaluation.

Approach:

  • A systematic review and meta-analysis was conducted.
  • Eleven studies comprising 1733 patients (743 SAV, 990 BAD) were analyzed.
  • Outcomes including mortality, need for aortic valve replacement, hemodynamic changes, and valve function were assessed.

Key Points:

  • No significant differences were observed in early, late, or total mortality between SAV and BAD.
  • Freedom from aortic valve replacement was comparable between the two intervention groups.
  • SAV demonstrated a significantly greater reduction in aortic systolic gradient and a lower rate of postprocedural aortic regurgitation compared to BAD.

Conclusions:

  • Both SAV and BAD are viable options for severe aortic stenosis regarding survival.
  • SAV provides superior hemodynamic improvement and better valve function post-intervention.
  • These findings suggest SAV may be preferred when significant gradient reduction and prevention of aortic regurgitation are key goals.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
18
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
37
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
31